Gene · 155
Papers3,802
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,802
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chronic β3-AR stimulation activates distinct thermogenic mechanisms in brown and white adipose tissue and improves systemic metabolism in aged mice. | Aging Cell | 2024 | 39177077 | PubTator, text mining | PubMed |
| Physiological and metabolic functions of the β3-adrenergic receptor and an approach to therapeutic achievements. | J Physiol Biochem | 2024 | 39145850 | PubTator, text mining | PubMed |
| β3-Adrenergic receptor overexpression in cardiomyocytes preconditions mitochondria to withstand ischemia-reperfusion injury. | Basic Res Cardiol | 2024 | 39134663 | PubTator, text mining | PubMed |
| Investigation of genetic markers associated to type 2 diabetes mellitus in Santarém-Pará. | Genet Mol Biol | 2024 | 39133695 | PubTator, text mining | PubMed |
| Hyaluronan Mediates Cold-Induced Adipose Tissue Beiging. | Cells | 2024 | 39120264 | PubTator, text mining | PubMed |
| Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron. | Front Pharmacol | 2024 | 39114356 | PubTator, text mining | PubMed |
| Thermogenic Fat as a New Obesity Management Tool: From Pharmaceutical Reagents to Cell Therapies. | Biomedicines | 2024 | 39062047 | PubTator, text mining | PubMed |
| Non-invasive mapping of brown adipose tissue activity with magnetic resonance imaging. | Nat Metab | 2024 | 39054361 | PubTator, text mining | PubMed |
| Molecular Mechanism of the β3AR Agonist Activity of a β-Blocker. | Chempluschem | 2024 | 39046191 | PubTator, text mining | PubMed |
| Semaphorin 6D tunes amygdalar circuits for emotional, metabolic, and inflammatory outputs. | Neuron | 2024 | 39002542 | PubTator, text mining | PubMed |
| Ligand-Receptor Interactions and Structure-Function Relationships in Off-Target Binding of the β3-Adrenergic Agonist Mirabegron to α1A-Adrenergic Receptors. | Int J Mol Sci | 2024 | 39000575 | PubTator, text mining | PubMed |
| The Effects of Vibegron Add-on Therapy on Alpha 1-Blocker Therapy for Sexual Function and Overactive Bladder Symptoms in Benign Prostatic Hyperplasia: A Prospective, Open-Label Study. | J Clin Med | 2024 | 38999505 | PubTator, text mining | PubMed |
| CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet. | Front Biosci (Landmark Ed) | 2024 | 38940054 | PubTator, text mining | PubMed |
| Frontiers and future perspectives of neuroimmunology. | Fundam Res | 2024 | 38933499 | PubTator, text mining | PubMed |
| CMKLR1 senses chemerin/resolvin E1 to control adipose thermogenesis and modulate metabolic homeostasis. | Fundam Res | 2024 | 38933207 | PubTator, text mining | PubMed |
| β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation. | Life (Basel) | 2024 | 38929758 | PubTator, text mining | PubMed |
| Subcutaneously transplanted xenogeneic protein recruits treg cells and M2 macrophages to induce browning of inguinal white adipose tissue. | Endocrine | 2024 | 38900356 | PubTator, text mining | PubMed |
| Editorial: Renal physiology: epithelial cell mechanics. | Front Physiol | 2024 | 38895517 | PubTator, text mining | PubMed |
| Roles of β-adrenoceptor Subtypes and Therapeutics in Human Cardiovascular Disease: Heart Failure, Tachyarrhythmias and Other Cardiovascular Disorders. | Handb Exp Pharmacol | 2024 | 38844580 | PubTator, text mining | PubMed |
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial. | J Urol | 2024 | 38708869 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/155/papers?page=8